Derivative Instruments (Tables)

9 Months Ended

Sep. 30, 2012

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Effect of derivative instruments designated as cash flow hedges

The effect of derivative instruments designated as cash flow hedges in our Condensed Consolidated Financial Statements for the third quarter and nine months ended September 30, 2012 and October 2, 2011 was as follows (in millions):

	Third Quarter						Nine Months
	2012			2011			2012			2011
Net gain (loss) recognized in AOCI (a)	$	3.3		$	(2.7	)	$	2.6		$	(2.9	)
Net gain (loss) reclassified from AOCI into cost of sales (a)	$	(0.4	)	$	0.2		$	(0.9	)	$	0.5
Net foreign exchange gain (loss) recognized in other income and expense (b)	$	0.1		$	0.4		$	0.4		$	0.6

(a) Effective portion

(b) Amount excluded from effectiveness testing

Fair values of derivative financial instruments

The fair values of the Company’s derivative financial instruments are presented below. All fair values for these derivatives were measured using Level 2 information as defined by the accounting standard hierarchy (in millions):

Asset/(Liability) Derivatives	Balance sheet location	September 30, 2012			January 1, 2012
Derivatives designated as hedging instruments:
Cash flow forward contracts	Other current assets	$	1.5		$	—
Cash flow forward contracts	Accrued liabilities	$	—		$	(2.0	)
Total derivatives designated as hedging instruments		1.5			(2.0		)
Derivatives not designated as hedging instruments:
Non-designated forward contracts	Other current assets	0.8			—
Non-designated forward contracts	Accrued liabilities	(0.3		)	(0.5		)
Total derivatives not designated as hedging instruments		0.5			(0.5		)
Total asset/(liability) derivatives		$	2.0		$	(2.5	)